American Heart Association Writing Group. Executive summary. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation, 2010; 121:e46–e215.
2.
FaehD., GutzwillerF., BoppM.Lower mortality from coronary heart disease and stroke at high altitudes in Switzerland. Circulation, 2009; 120:495–501.
3.
WisemanC., FreerL., HungE.Physical and medical characteristics of successful and unsuccessful summiteers of Mount Everest in 2003. Wilderness Environ Med, 2006; 17:103–108.
4.
FérézouJ., RichaletJ.P., CosteT., RathatC.Changes in plasma lipids and lipoprotein cholesterol during a high altitude mountaineering expedition (4800 m). Eur J Appl Physiol Occup Physiol, 1988; 57:740–745.
5.
Domínguez CoelloS., Cabrera De LeónA., Bosa OjedaF., Pérez MéndezL.I., Díaz GonzálezL., Aguirre-JaimeA.J.High density lipoprotein cholesterol increases with living altitude. Int J Epidemiol, 2000; 29:65–70.
6.
SiquésP., BritoJ., León-VelardeF., BarriosL., De La CruzJ.J., LópezV., et al.Hematological and lipid profile changes in sea-level natives after exposure to 3550-m altitude for 8 months. High Alt Med Biol, 2007; 8:286–295.
